ALX Oncology
CA - South SFBiotechnology
Focus: ALX Oncology is an immuno-oncology biotech focused on developing novel therapeutic approaches for advanced solid tumors and hematologic malignancies. The company operates as a clinical-stage biotech with a lean footprint in South San Francisco.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Open Jobs
3
Should You Work at ALX Oncology?
AI assessmentBest suited for mission-driven immuno-oncology specialists willing to accept pre-revenue biotech risk for early technical influence and equity upside.
Why Work Here
- Ground-floor opportunity at an immuno-oncology specialist with 8 active clinical trials across early to mid-stage programs
- Focused pipeline allows deep expertise development in emerging immune checkpoint modulation (evorpacept platform)
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ALX2004
Non-small Cell Lung CancerClinical Trials (1)
NCT07085091A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Phase 1Help build intelligence for ALX Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.